Javitt Jonathan C bought NRXP
July 28, 2026 · Form 4 insider transaction
Javitt Jonathan C bought 150,000 shares of NRx Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 99 days after the transaction.
Direction
Acquired (buy-side)
Shares
150,000
Price
$0.00
Total value
N/A
InsiderJavitt Jonathan C
RoleOfficer, Director, 10% owner
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJuly 28, 2026
Filing dateNovember 4, 2026
Shares owned after150,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSUs') represents a contingent right to receive one share of the Issuer's common stock at the time of vesting for no consideration.; The restricted stock units were granted under the NRx Pharmaceuticals, Inc. 2021 Omnibus Incentive Plan, as amended. The RSUs vest in three equal annual installments on July 28, 2027, July 28, 2028 and July 28, 2029, subject to the reporting person's continued service through each vesting date.